A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
Clinical trial NCT06701526 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06701526
- Sponsor
- H. Lundbeck A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2026-06-05
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.